Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Nordin Sincere
- ·The full record, as it builds
Funding rounds
No funding rounds for Nordin Sincere are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nordin Sincere
Developer of an AI-powered ultrasound diagnostic and treatment platform designed to deliver non-invasive, metabolic-free, and precision-driven plastic surgery and tissue repair. The company offers integrated high-resolution ultrasound imaging, AI-assisted diagnostics, and personalized treatment capabilities, enabling healthcare professionals to deliver safer, more accurate, and efficient patient care.
- Sector
- Information Technology
- HQ
- Suzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Nordin Sincere doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nordin Sincere shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nordin Sincere in its N-PORT filings yet. We sweep new filings monthly.